Temefos
Temefos (also known as Abate) is an organophosphate pesticide that is primarily used to control mosquito larvae. It is a white, crystalline solid with a slight sulfur odor.
History[edit]
Temefos was first registered in the United States in 1965 for use in controlling mosquito larvae. It is currently registered for use in both public health and pest control.
Uses[edit]
Temefos is used to control mosquito larvae in a variety of habitats. These include freshwater marshes, salt marshes, and non-crop wetlands. It is also used in residential areas, such as in ornamental fountains, swimming pools, and other water-holding containers where mosquitoes may breed.
Mode of Action[edit]
Temefos works by inhibiting the activity of acetylcholinesterase, an enzyme that is essential for normal nerve impulse transmission. In insects, this leads to an accumulation of acetylcholine, causing paralysis and death.
Health Effects[edit]
Exposure to temefos can cause a variety of health effects in humans. These include nausea, vomiting, diarrhea, abdominal cramps, sweating, blurred vision, and headache. In severe cases, it can cause seizures, loss of consciousness, and respiratory failure.
Environmental Impact[edit]
Temefos is highly toxic to aquatic organisms, including fish and invertebrates. It is also toxic to birds and bees. However, it is not likely to accumulate in the environment due to its low potential for bioaccumulation and its relatively short half-life in water and soil.
Regulatory Status[edit]
In the United States, temefos is classified as a Restricted Use Pesticide (RUP) by the Environmental Protection Agency (EPA). This means that it can only be used by certified applicators or persons under their direct supervision.
See Also[edit]
This insecticide-related article is a stub. You can help WikiMD by expanding it.
-
Temefos 3D
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian